Asklêpios BioPharmaceutical Inc Company Profile

16:51 EST 10th December 2018 | BioPortfolio

Asklêpios BioPharmaceutical Inc., (“AskBio”) is a biotechnology company engaged in the development and delivery of novel protein and cellular based therapies through design of proprietary Biological Nano Particles (“BNP”). AskBio commenced operations in 2003, and is operating in a clinical research capacity in Chapel Hill, North Carolina.


510 Meadownmount Village Circle#112,
Chapel Hill
North Carolina
United States of America


Phone: 919-933-4990

News Articles [45 Associated News Articles listed on BioPortfolio]

SGS reveals investment into North American biopharmaceutical testing capabilities

Biopharmaceutical analytical and bioanalytical contract solutions provider, SGS, has revealed it is investing more than $1.7 million to expand its North American biopharmaceutical testing capabilities...

SGS investing $1.7m to expand biopharmaceutical testing capabilities

The biopharmaceutical analytical and bioanalytical contract solutions provider SGS is investing more than $1.7m to expand its North American biopharmaceutical testing capabilities.

Offering packet solutions for biopharmaceutical processes

ARTES Biotechnology, and Minapharm Pharmaceuticals and Chemical Industries have made a business alliance to out-license their respective biopharmaceutical technologies

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that the Company has launched a new China Advisory Service to help global biopharmaceutical...

GSK: Ian Tomlinson talks about building a biopharmaceutical presence within GSK

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Ian Tomlinson, Senior Vice President of Worldwide Business Development & Biopharmaceut...

Here’s how America’s biopharmaceutical companies lead the way in development of innovative new medicines

In today’s new era of medicine, America’s biopharmaceutical companies are conducting some of the most complex and difficult research in the world to develop innovative treatments for p...

SGS expands biopharma testing capabilities in Switzerland

Biopharmaceutical analytical and bioanalytical contract solutions provider, SGS, has revealed it is expanding its biopharmaceutical testing capabilities in Geneva, Switzerland with a new 200 m2 lab.

GE Healthcare Acquires Wave Biotech LLC, Broadening Capabilities In Growing Biopharmaceutical Manufacture Segment

GE Healthcare, a unit of General Electric Company, today announced it has acquired Wave Biotech LLC, a supplier of innovative disposable manufacturing technologies for the biopharmaceutical industry

Drugs and Medications [0 Results]


PubMed Articles [52 Associated PubMed Articles listed on BioPortfolio]

The inherent risks associated with newly traded biopharmaceutical firms.

Here, we provide a comprehensive study related to the risks of all biopharmaceutical firms going public in the USA between 1996 and 2015. We found 355 firms that met our requirements for being in the ...

Rejoinder to Mr. Peter J. Laud.

Biopharmaceutical Optimization in neglected diseases for paediatric patients by applying the provisional paediatric Biopharmaceutical Classification System.

Unavailability and lack of appropriate, effective and safe formulations are common problems in paediatric therapeutics. Key factors such as swallowing abilities, organoleptic preferences and dosage re...

Expanding bedside filtration - a powerful tool to protect patients from protein aggregates.

Protein immunogenicity is intensively researched by academics, biopharmaceutical companies and authorities as it can compromise the safety and efficacy of a biopharmaceutical drug. So far the exact pr...

Comments on "A Bayesian meta-analysis method for estimating risk difference of rare events".

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

Mycobacterium Vaccae for Injection (Trade Name "Vaccae") is a kind of bio-products developed by Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd.,and got "The New Drug Certificate "in 1999...

A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects

GSK3128349 is a small protein molecule (biopharmaceutical) that binds to albumin in the body, and by itself, has no pharmacological action. A pharmacologically active drug can be attached ...

Juvista in the Non-surgical Improvement of Existing Scars

Renovo, a Biopharmaceutical company involved in the development of drugs to improve the appearance of scars and enhance wound healing, are proposing to carry out research in improving the ...

Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet

Epclusa® is a pan-genotypic, once-daily tablet for the treatment of chronic hepatitis C virus (HCV) infection containing the NS5B- polymerase inhibitor sofosbuvir (SOF, nucleotide analogu...

Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma

Background and objective The introduction of a proteasome inhibitor bortezomib has significantly improved response rates and overall survival in patients with multiple myeloma (MM), and i...

Companies [902 Associated Companies listed on BioPortfolio]

Asklêpios BioPharmaceutical Inc

Asklêpios BioPharmaceutical Inc., (“AskBio”) is a biotechnology company engaged in the development and delivery of novel protein and cellular based therapies through design of proprietary Biologi...


A INTERFAZ desenvolve ações nas áreas de desenvolvimento organizacional e promoção da saúde incluindo capacitação de recursos humanos, reorientação de serviços, consultoria técnica e aten...

Bavarian Nordic Research Institute A/S

Bavarian Nordic is a commercially viable international biopharmaceutical company through:Biopharmaceutical innovations Novel prophylactic and therapeutic approaches Development, production, testing an...

bde BioPharmaceutical Resources

bde BioPharmaceutical Resources is affiliated with a consortium of companies & consultants whose expertise can be utilized to perform a full spectrum of regulatory, scientific & manufacturing function...


A Hovione foi fundada em 1959 por Ivan Villax, investigador químico, empenhado no desenvolvimento de tetraciclinas e corticoesteroídes anti-inflamatórios. O sucesso da investigação, financiada pe...

More Information about "Asklêpios BioPharmaceutical Inc" on BioPortfolio

We have published hundreds of Asklêpios BioPharmaceutical Inc news stories on BioPortfolio along with dozens of Asklêpios BioPharmaceutical Inc Clinical Trials and PubMed Articles about Asklêpios BioPharmaceutical Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Asklêpios BioPharmaceutical Inc Companies in our database. You can also find out about relevant Asklêpios BioPharmaceutical Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record